Please turn on your JavaScript for this page to function normally.
Novartis
Cohesity announces valuation of $3.7B following a growth in annual recurring revenues
Cohesity announced a new company valuation of $3.7 billion, which is $1.2 billion higher than its valuation less than 12 months ago. This dramatic growth in valuation …
Novartis leverages AWS’ portfolio of cloud services to build an enterprise-wide data and analytics platform
Amazon Web Services (AWS), an Amazon.com company, announced a multi-year strategic collaboration with Novartis to reimagine this leading pharmaceutical company’s core …